Acadia Pharmaceuticals (ACAD)

Acadia Pharmaceuticals (ACAD) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• ACAD last traded at $20.38, -1.02% on the day.
• Acadia Pharmaceuticals: market cap $3.55B, P/E 9.1, revenue $1.14B over the last four quarters, next earnings 2026-11-04.
• Over the past year ACAD returned -10.38%; year to date -23.70%.

Updated 2026-11-02 18:01 UTC